A Novel Human Cytomegalovirus Locus Modulates Cell Type-Specific Outcomes of Infection

English version České info

Clinical strains of HCMV encode 20 putative ORFs within a region of the genome termed ULb′ that are postulated to encode functions related to persistence or immune evasion. We have previously identified ULb′-encoded pUL138 as necessary, but not sufficient, for HCMV latency in CD34⁺ hematopoietic progenitor cells (HPCs) infected in vitro. pUL138 is encoded on polycistronic transcripts that also encode 3 additional proteins, pUL133, pUL135, and pUL136, collectively comprising the UL133-UL138 locus. This work represents the first characterization of these proteins and identifies a role for this locus in infection. Similar to pUL138, pUL133, pUL135, and pUL136 are integral membrane proteins that partially co-localized with pUL138 in the Golgi during productive infection in fibroblasts. As expected of ULb′ sequences, the UL133-UL138 locus was dispensable for replication in cultured fibroblasts. In CD34⁺ HPCs, this locus suppressed viral replication in HPCs, an activity attributable to both pUL133 and pUL138. Strikingly, the UL133-UL138 locus was required for efficient replication in endothelial cells. The association of this locus with three context-dependent phenotypes suggests an exciting role for the UL133-UL138 locus in modulating the outcome of viral infection in different contexts of infection. Differential profiles of protein expression from the UL133-UL138 locus correlated with the cell-type dependent phenotypes associated with this locus. We extended our in vitro findings to analyze viral replication and dissemination in a NOD-scid IL2Rγ_c^null-humanized mouse model. The UL133-UL138_NULL virus exhibited an increased capacity for replication and/or dissemination following stem cell mobilization relative to the wild-type virus, suggesting an important role in viral persistence and spread in the host. As pUL133, pUL135, pUL136, and pUL138 are conserved in virus strains infecting higher order primates, but not lower order mammals, the functions encoded likely represent host-specific viral adaptations.

Vyšlo v časopise: A Novel Human Cytomegalovirus Locus Modulates Cell Type-Specific Outcomes of Infection. PLoS Pathog 7(12): e32767. doi:10.1371/journal.ppat.1002444
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002444

Souhrn

Zdroje

1. HorvathRCernyJBenedikJJrHoklJJelinkovaI 2000 The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 16 17 24

2. StreblowDNOrloffSLNelsonJA 2001 Do pathogens accelerate atherosclerosis? J Nutr 131 2798S 2804S

3. MossP 2010 The emerging role of cytomegalovirus in driving immune senescence: a novel therapeutic opportunity for improving health in the elderly. Curr Opin Immunol 22 529 534

4. BrunnerSHerndler-BrandstetterDWeinbergerBGrubeck-LoebensteinB 2011 Persistent viral infections and immune aging. Ageing Res Rev 10 362 369

5. PawelecGDerhovanessianE 2011 Role of CMV in immune senescence. Virus Res 157 175 179

6. HighKP 2005 Chronic infection and frailty: surrogate markers, associations, and causality. J Am Geriatr Soc 53 906 908

7. SchmaltzHNFriedLPXueQLWalstonJLengSX 2005 Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 53 747 754

8. WangGCKaoWHMurakamiPXueQLChiouRB 2010 Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 171 1144 1152

9. BoeckhMNicholsWGPapanicolaouGRubinRWingardJR 2003 Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant 9 543 558

10. HuangLCrothersK 2009 HIV-associated opportunistic pneumonias. Respirology 14 474 485

11. KedharSRJabsDA 2007 Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Herpes 14 66 71

12. MocarskiESShenkTPassRF 2007 Cytomegaloviruses. KnipeDMHowleyPM Fields Virology.5 ed Philadelphia Lippincott, Williams & Wilkins 2701 2673

13. ArvinAMFastPMyersMPlotkinSRabinovichR 2004 Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis 39 233 239

14. SyggelouAIacovidouNKloudasSChristoniZPapaevangelouV 2010 Congenital cytomegalovirus infection. Ann N Y Acad Sci 1205 144 147

15. ChaTATomEKembleGWDukeGMMocarskiES 1996 Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70 78 83

16. DolanACunninghamCHectorRDHassan-WalkerAFLeeL 2004 Genetic content of wild-type human cytomegalovirus. J Gen Virol 85 1301 1312

17. MurphyEYuDGrimwoodJSchmutzJDicksonM 2003 Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 100 14976 14981

18. GoodrumFReevesMSinclairJHighKShenkT 2007 Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110 937 945

19. PetrucelliARakMGraingerLGoodrumF 2009 Characterization of a Novel Golgi-localized Latency Determinant Encoded by Human Cytomegalovirus. J Virol 83 5615 5629

20. LeVTTrillingMHengelH 2011 The Cytomegaloviral Protein pUL138 Acts as Potentiator of TNF Receptor 1 Surface Density to Enhance ULb′-encoded modulation of TNF-{alpha} Signaling. J Virol 85 13260 13270

21. MontagCWagnerJAGruskaIVetterBWiebuschL 2011 The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression. J Virol 85 11409 11421

22. GraingerLCicchiniLRakMPetrucelliAFitzgeraldKD 2010 Stress-Inducible Alternative Translation Initiation of Human Cytomegalovirus Latency Protein pUL138. J Virol 84 9472 9486

23. PischelKDLittleJR 1979 Limited trypsin cleavage distinguishes MHC and thymus-leukemia antigens. J Immunol 123 551 556

24. StamNJSpitsHPloeghHL 1986 Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137 2299 2306

25. GoodrumFDJordanCTHighKShenkT 2002 Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci U S A 99 16255 16260

26. GoodrumFJordanCTTerhuneSSHighKPShenkT 2004 Differential outcomes of human cytomegalovirus infection in primitive hematopoietic subpopulations. Blood 104 687 695

27. SmithMSGoldmanDCBaileyASPfaffleDLKreklywichCN 2010 Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8 284 291

28. DattaRSMeachamCSamadBNeyerCSjolanderK 2009 Berkeley PHOG: PhyloFacts orthology group prediction web server. Nucleic Acids Res 37 W84 89

29. KelleyLASternbergMJ 2009 Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4 363 371

30. TompaP 2005 The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett 579 3346 3354

31. OxfordKLEberhardtMKYangKWStrelowLKellyS 2008 Protein coding content of the UL)b′ region of wild-type rhesus cytomegalovirus. Virology 373 181 188

32. TomasecPWangECDavisonAJVojtesekBArmstrongM 2005 Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6 181 188

33. WillsMRAshiruOReevesMBOkechaGTrowsdaleJ 2005 Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 175 7457 7465

34. BenedictCAButrovichKDLurainNSCorbeilJRooneyI 1999 Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162 6967 6970

35. PooleEKingCASinclairJHAlcamiA 2006 The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism. Embo J 25 4390 4399

36. PenfoldMEDairaghiDJDukeGMSaederupNMocarskiES 1999 Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A 96 9839 9844

37. BruneWNevelsMShenkT 2003 Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein. J Virol 77 11633 11643

38. HicksSWMachamerCE 2005 Golgi structure in stress sensing and apoptosis. Biochim Biophys Acta 1744 406 414

39. MillerCLEavesCJ 2002 Long-term culture-initiating cell assays for human and murine cells. KlugCAJordanCT Hematopoietic Stem Cell Protocols Totowa Humana Press 123 141

40. WarmingSCostantinoNCourtDLJenkinsNACopelandNG 2005 Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33 e36

41. YuDEllisHMLeeECJenkinsNACopelandNG 2000 An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci U S A 97 5978 5983

42. HahnGKhanHBaldantiFKoszinowskiUHRevelloMG 2002 The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J Virol 76 9551 9555

43. RevelloMGLilleriDZavattoniMStronatiMBollaniL 2001 Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. J Infect Dis 184 1078 1081

44. SinzgerCHahnGDigelMKatonaRSampaioKL 2008 Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89 359 368

45. PfafflMW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 e45

46. HuYSmythGK 2009 ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347 70 78